Genotype-independent in vivo oxidative stress following a methionine loading test: maximal platelet activation in subjects with early-onset thrombosis

Thromb Res. 2011 Oct;128(4):e43-8. doi: 10.1016/j.thromres.2011.05.017. Epub 2011 Jun 12.

Abstract

Background: Methionine ingestion (100mg/kg) identifies subjects in whom fasting total homocysteine (tHcy) may be normal but the post-methionine load (PML) tHcy is abnormally high.

Methods: In 96 subjects [54 M/42 F, 40.4 ± 12.3 yrs old; 28 with the 68 bp844 ins of the cystathionine-β-synthase gene (CBSins+); 20 homozygotes for the C677T mutation of the methylene-tetrahydrofolate reductase gene (MTHFR++); 13 with the combination of the two, and 35 without any of them], we have evaluated in vivo oxidative stress and platelet activation, as reflected by urinary excretions of 8-iso-PGF(2α) and of 11-dehydro-TXB(2) respectively, before and after a methionine load test (PML). A history of early-onset thrombosis (18 arterial, 32 venous, 2 both) was present in 52/96 of them.

Results: Baseline; tHcy was highest in MTHFR++ carriers (p < 0,05); 8-iso-PGF(2α) and 11-dehydro-TXB(2) levels were independent of sex, MTHFR++ and/or CBSins + (p > 0.05). PML; The ~3-fold increase (p < 0.01 vs baseline) in tHcy reached a plateau within 6-8 hrs. Mean PML tHcy was maximal in MTHFR++ carriers (p = 0.000). 8-iso-PGF(2α) and 11-dehydro-TXB(2) increase reached a maximum within 4 hrs. 11-dehydro-TXB(2) increase was highest (p = 0.023 vs baseline) in subjects with a history of thrombosis. Baseline 11-dehydro-TXB(2) and a history of thrombosis independently predicted PML 11-dehydro-TXB(2) (β = 0.287, p = 0.000 and β = 0.308, p = 0.026, respectively).The PML increase in 8-iso-PGF(2α) or in 11-dehydro-TXB(2) were comparable in the different genotypes (p > 0.05).

Conclusion: Regardless genotypes associated with moderate hyperhomocysteinemia, following a methionine loading test, in vivo oxidative stress and platelet activation occur, being the latter maximal in subjects with a history of early-onset thrombosis.

MeSH terms

  • Adult
  • Age of Onset
  • Analysis of Variance
  • Biomarkers / blood
  • Biomarkers / urine
  • Case-Control Studies
  • Chi-Square Distribution
  • Cystathionine beta-Synthase / genetics
  • Cystathionine beta-Synthase / metabolism
  • Dinoprost / analogs & derivatives
  • Dinoprost / urine
  • Female
  • Homocysteine / blood*
  • Homozygote
  • Humans
  • Hyperhomocysteinemia / blood
  • Hyperhomocysteinemia / diagnosis*
  • Hyperhomocysteinemia / genetics
  • Italy
  • Linear Models
  • Male
  • Methionine*
  • Methylenetetrahydrofolate Reductase (NADPH2) / genetics
  • Methylenetetrahydrofolate Reductase (NADPH2) / metabolism
  • Middle Aged
  • Mutation
  • Oxidative Stress / genetics*
  • Phenotype
  • Platelet Activation* / genetics
  • Platelet Function Tests*
  • Thrombosis / blood
  • Thrombosis / diagnosis*
  • Thrombosis / genetics
  • Thromboxane B2 / analogs & derivatives
  • Thromboxane B2 / urine
  • Time Factors

Substances

  • Biomarkers
  • Homocysteine
  • 8-epi-prostaglandin F2alpha
  • Thromboxane B2
  • 11-dehydro-thromboxane B2
  • Methionine
  • Dinoprost
  • Methylenetetrahydrofolate Reductase (NADPH2)
  • Cystathionine beta-Synthase